New COVID variant JN.1 could disrupt holiday plans.

A new COVID-19 variant, JN.1, has emerged and is causing concern among experts. However, recent research suggests that the 2023-2024 COVID-19 vaccine is effective against this variant. The low vaccination rate, with less than 16% of U.S. adults vaccinated, has led some experts to urge the CDC to encourage the public to get vaccinated before the holiday season. The JN.1 variant is an offspring of the BA.2.86 variant, which was initially identified as potentially more infectious. While the risk of JN.1 is currently low, it has spread to many countries and is contributing to a rise in COVID-19 cases. Mitigation measures, such as getting vaccinated, improving indoor ventilation, and wearing masks, are recommended to prevent the spread of the variant. [Extracted from the article]

Copyright of Pediatric News is the property of Frontline Medical Communications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)